NCT06301464Recruitment Completed
Pepsinogen II and Helicobacter Pylori Test in Gastric Cancer
Validation of Serum Pepsinogen II and Helicobacter Pylori Test in the Detection of Gastric Cancer in South Korea
Seoul National University Bundang HospitalClinicalTrials.gov
Study focus
- Disease/Condition
- Gastric Cancer
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Seoul National University Bundang Hospital
- Location
- Seongnam-si, South Korea
Timeline & enrollment
- Phase
- N/A
- Start date
- Mar 01, 2003
- End date
- Dec 31, 2025
- Enrollment
- 24000 participants
Primary outcome
The level of serum pepsinogens
Summary
The aim of this study to validate the role of pepsinogens in gastric cancer screening.
ICD-10 classifications
Gastric ulcerMalignant neoplasm of stomachMalignant neoplasm: Body of stomachCarcinoma in situ: StomachMalignant neoplasm: Stomach, unspecified
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06301464
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06301464 through Pure Global AI's free database. This phase not specified trial is sponsored by Seoul National University Bundang Hospital and is currently Recruitment Completed. The study focuses on Gastric Cancer. Target enrollment is 24000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.